Piedmont Investment Advisors LLC Buys 673 Shares of CME Group Inc (CME)
Piedmont Investment Advisors LLC raised its stake in shares of CME Group Inc (NASDAQ:CME) by 0.9% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 73,118 shares of the financial services provider’s stock after purchasing an additional 673 shares during the quarter. Piedmont Investment Advisors LLC’s holdings in CME Group were worth $9,921,000 as of its most recent filing with the Securities and Exchange Commission.
Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Fiduciary Trust Co. bought a new position in shares of CME Group in the second quarter valued at approximately $105,000. Valeo Financial Advisors LLC bought a new position in shares of CME Group in the third quarter valued at approximately $124,000. Quadrant Capital Group LLC raised its stake in shares of CME Group by 13.6% in the second quarter. Quadrant Capital Group LLC now owns 944 shares of the financial services provider’s stock valued at $111,000 after acquiring an additional 113 shares during the last quarter. San Francisco Sentry Investment Group CA bought a new position in shares of CME Group in the second quarter valued at approximately $129,000. Finally, People s United Financial Inc. raised its stake in shares of CME Group by 11.5% in the second quarter. People s United Financial Inc. now owns 1,063 shares of the financial services provider’s stock valued at $133,000 after acquiring an additional 110 shares during the last quarter. 83.17% of the stock is currently owned by institutional investors.
CME has been the subject of a number of research analyst reports. BidaskClub upgraded shares of CME Group from a “hold” rating to a “buy” rating in a research note on Friday, August 18th. Keefe, Bruyette & Woods reiterated a “hold” rating and issued a $127.00 target price on shares of CME Group in a research note on Friday, August 18th. UBS reiterated a “buy” rating and issued a $135.00 target price (up previously from $134.00) on shares of CME Group in a research note on Wednesday, September 6th. Barclays initiated coverage on shares of CME Group in a research note on Friday, September 8th. They issued an “overweight” rating and a $139.00 target price for the company. Finally, Wells Fargo & Company lifted their target price on shares of CME Group from $130.00 to $145.00 and gave the company a “market perform” rating in a research note on Wednesday, October 4th. One investment analyst has rated the stock with a sell rating, three have given a hold rating and eight have issued a buy rating to the stock. The company currently has a consensus rating of “Buy” and a consensus price target of $141.75.
In other CME Group news, insider Hilda Harris Piell sold 1,350 shares of the company’s stock in a transaction on Thursday, October 5th. The shares were sold at an average price of $138.00, for a total transaction of $186,300.00. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CFO John W. Pietrowicz sold 5,175 shares of the company’s stock in a transaction on Thursday, November 2nd. The shares were sold at an average price of $139.70, for a total transaction of $722,947.50. The disclosure for this sale can be found here. Insiders sold a total of 36,628 shares of company stock valued at $5,288,800 in the last 90 days. 0.57% of the stock is currently owned by corporate insiders.
CME Group Inc (NASDAQ:CME) opened at $153.03 on Wednesday. The company has a quick ratio of 1.05, a current ratio of 1.05 and a debt-to-equity ratio of 0.11. CME Group Inc has a 1 year low of $113.27 and a 1 year high of $155.29. The firm has a market cap of $51,786.25, a P/E ratio of 31.95, a P/E/G ratio of 3.14 and a beta of 0.73.
CME Group (NASDAQ:CME) last posted its quarterly earnings data on Thursday, October 26th. The financial services provider reported $1.19 earnings per share for the quarter, topping the consensus estimate of $1.16 by $0.03. CME Group had a net margin of 40.94% and a return on equity of 7.89%. The firm had revenue of $890.80 million during the quarter, compared to analysts’ expectations of $890.22 million. During the same quarter in the previous year, the company posted $1.05 EPS. CME Group’s revenue was up 5.8% on a year-over-year basis. analysts expect that CME Group Inc will post 4.78 earnings per share for the current fiscal year.
The business also recently disclosed a None dividend, which will be paid on Monday, January 15th. Investors of record on Thursday, December 28th will be given a $3.50 dividend. The ex-dividend date is Wednesday, December 27th. CME Group’s dividend payout ratio (DPR) is presently 59.86%.
About CME Group
CME Group Inc, through its exchanges, provides products across all asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products and metals. The Company’s segment primarily consists of the Chicago Mercantile Exchange Inc (CME), Board of Trade of the City of Chicago, Inc (CBOT), New York Mercantile Exchange, Inc (NYMEX) and Commodity Exchange, Inc (COMEX) exchanges.
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.